Niederer Kraft Frey advised Schweiter Technologies AG, a global group specialising in the field of composite materials and composite solutions in lightweight construction, on the extension of its PET foam production in Poland and the
Tags :Slider
As they look to transform in the wake of complex digital and regulatory change, legal departments across the globe are facing a mounting list of operational challenges. It emerges from the 2021 EY Law Survey, conducted
Loomis, the Sweden-based and listed provider of cash handling services for banks, retailers and other commercial clients, has, through its wholly owned subsidiary Loomis Schweiz, entered into an agreement to acquire certain assets and liabilities
Imaweb, a developer of software solutions for automotive manufacturers and dealers (a portfolio company of PSG), purchased all shares in Stieger Software AG, a provider of comprehensive software solutions for garages, motorcycle businesses and shipyards. &
Nice & Green, an independent Switzerland-based provider of innovative alternative financing solutions for small and mid-sized listed companies headquartered in Nyon, Switzerland, announced a minority growth investment by Artemis Group, owned by Swiss entrepreneur Michael
Gi Group, Italy’s largest multinational staffing company and one of Europe’s top six staffing companies, has completed the acquisition of Jobtome International, one of the world’s largest online job aggregators based in
Medical Properties Trust, specialized for 20 years in acquiring and managing healthcare facilities, has increased its stake in Infracore SA to 70% by acquiring the 30% stake of Bâloise Group. This acquisition, which was announced on March 25, 2021,
On March 23, 2021, Dufry One launched, and on March 30, 2021, successfully completed the issuance of CHF 500 million guaranteed senior convertible bonds due 2026 (the 2026 Bonds). The 2026 Bonds are conditionally convertible into ordinary shares of Dufry and are guaranteed
BridgeBio Pharma, through its affiliate QED Therapeutics, and Helsinn Group announced a global collaboration and licensing agreement to further develop and commercialize QED Therapeutics’ FGFR1-3 inhibitor, infigratinib, in oncology and all other indications except
Deal & transactions
Kellerhals Carrard advised FISCHER entering into a strategic collaboration with Weichai
The privately controlled FISCHER Spindle Group in Switzerland, world technology operator in fuel cell compressor technology and Weichai Power, a listed 10bn Shandong company and one of the world technology operators of hydrogen fuel cell
